Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary leiomyosarcoma of bone.

T Y Wang, R A Erlandson, R C Marcove

    Archives of Pathology & Laboratory Medicine
    |February 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tongue Cancer.

    Postgraduate medicine·2016
    Same author

    Hepatobiliary neuroendocrine carcinoma in cats: a clinicopathologic, immunohistochemical, and ultrastructural study of 17 cases.

    Veterinary pathology·2005
    Same author

    Canine hepatic neuroendocrine carcinoma: an immunohistochemical and electron microscopic study.

    Veterinary pathology·2005
    Same author

    Feline cystic thymoma: a clinicopathologic, immunohistologic, and electron microscopic study of 14 cases.

    Journal of feline medicine and surgery·2003
    Same author

    Neuroendocrine carcinoma of the nasopharynx in a dog.

    Veterinary pathology·2002
    Same author

    Low-grade osteogenic sarcoma arising in medullary and surface osseous locations.

    American journal of clinical pathology·2002
    Same journal

    Assessing Human Epidermal Growth Factor Receptor 2 in Urothelial Carcinoma: Insights From Clinical Practice Into Scoring Criteria, Histologic Subtypes, and Genomic Characteristics Across Disease Sites.

    Archives of pathology & laboratory medicine·2026
    Same journal

    Cross-Reactivity of TPIT Antibody Clone OTI2G1 in Chordoma: Structural Mechanisms and Diagnostic Implications.

    Archives of pathology & laboratory medicine·2026
    Same journal

    Paracoccidioidomycosis at Autopsy: A Case Series and Literature Review.

    Archives of pathology & laboratory medicine·2026
    Same journal

    Accuracy of Cytology Diagnosis for Well Differentiated Neuroendocrine Tumors: Assessment by the College of American Pathologists Non-Gynecologic Slide Program.

    Archives of pathology & laboratory medicine·2026
    Same journal

    Serum Immunofixation Electrophoresis Guidance Conflict: A Call to Harmonize.

    Archives of pathology & laboratory medicine·2026
    Same journal

    In Reply.

    Archives of pathology & laboratory medicine·2026
    See all related articles

    A rare tibial leiomyosarcoma in a 65-year-old man showed two distinct cell types. Early diagnosis and aggressive surgical treatment, like wide excision or amputation, improve prognosis for this bone cancer.

    Area of Science:

    • Oncology
    • Pathology
    • Orthopedic Surgery

    Background:

    • Primary leiomyosarcoma of bone is an exceptionally rare malignant mesenchymal tumor.
    • Leiomyosarcomas typically arise in soft tissues, making bone involvement unusual.

    Observation:

    • A case of primary leiomyosarcoma in the proximal tibia of a 65-year-old male patient is presented.
    • Histochemical and electron microscopy confirmed the diagnosis, revealing two distinct neoplastic cell populations.
    • Ultrastructural analysis identified type 1 cells resembling smooth muscle cells and type 2 cells with pleomorphism and thick myofilaments.

    Findings:

    • The tumor likely originated from vascular smooth muscle cells within the tibia.
    • An alternative origin from perivascular, multipotential mesenchymal cells cannot be excluded.

    Related Experiment Videos

  • Ultrastructural heterogeneity suggests complex cellular differentiation within the leiomyosarcoma.

    • Implications:

    • Prognosis for tibial leiomyosarcoma is poor with inadequate surgical excision and irradiation.
    • Aggressive surgical management, including wide excision or major amputation, offers a more promising outlook.
    • This case highlights the importance of considering rare bone tumors and emphasizes optimal treatment strategies for improved patient outcomes.